PharmiWeb49m
Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market
License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), ...
PharmiWeb49m
Adnexus Biotechnologies Inc. Unveils AI-Driven Malaria Cure with Trapicolast
Adnexus Biotechnologies Inc. is at the forefront of the battle against malaria by developing Trapicolast, an antimalarial ...
PharmiWeb1h
CORRECTION: 2025's Top-Rated EHR Vendors Across 40 Medical & Surgical Specialties: Black Book Insights Into Innovation and Client-Centric Excellence
Correction: This release has been updated to reflect accurate specialty-focused EHR top ratings. NextGen Healthcare has achieved five specialty-focused EHR top ratings, including Cardiovascular ...
PharmiWeb2h
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the ...
PharmiWeb4h
Shanghai Korain Biotech Leverages Bioz Badges to Boost Sales and Highlight Product Credibility
PALO ALTO, CALIFORNIA / ACCESSWIRE / January 7, 2025 / Bioz, Inc., a leader in AI-driven product engagement and citation analytics, is proud to announce the successful integration of Bioz Badges onto ...
PharmiWeb4h
Pentixapharm Receives EUR 6.77 Million for Intangible Assets Formerly Developed by Glycotope
AgreementPentixapharm Receives EUR 6.77 Million for Intangible Assets Formerly Developed by Glycotope 07.01.2025 / 10:30 CET/CESTThe issuer is solely responsible for the content of this ...
PharmiWeb7h
Global Excessive Daytime Sleepiness Market is expected to reach USD 12.39 Billion by 2033 with a fast-expanding CAGR of 8.8%
The excessive daytime sleepiness market drowsiness was projected to be worth USD 4.9 billion in 2022. With an expected CAGR of 8.8% from 2023 to 2033, this market is expected to earn USD 5.33 billion ...
PharmiWeb7h
Global Home Blood Testing Devices Market is anticipated to hit USD 45.6 Billion by 2033
According to the latest data, the global home blood testing devices market is currently valued at an impressive USD 14.76 billion. These estimations project a continual upward trajectory, with an ...
PharmiWeb7h
Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division
Medtronic will act as the exclusive sales agent of MagnetOsTM for Kuros Biosciences USA, Inc. in mutually agreed upon sales territories for use in spine surgeriesKuros will work collaboratively to ...
PharmiWeb15h
Protagonist Therapeutics Reports Granting of Inducement Awards
NEWARK, CALIFORNIA / ACCESSWIRE / January 6, 2025 / Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on January 2, 2025, it issued inducement awards to Newman Yeilding, M.D., upon his ...
PharmiWeb21h
Frontage Announces Co-CEO Promotions
Frontage Holdings Corporation today announced that Dr. Abdul Mutlib has decided to step aside from his current role as CEO of the company to facilitate the Company's leadership succession planning and ...
PharmiWeb22h
Santhera Enters into Supply and Distribution Agreement for AGAMREE® (Vamorolone) with Clinigen Group
Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of AGAMREE® (Vamorolone) in countries where the product ...